XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

167 hedge funds and large institutions have $2.56B invested in Acceleron Pharma Inc. in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
-3
Holders Change %
-1.76%
% of All Funds
3.82%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.21%
New
24
Increased
51
Reduced
58
Closed
27
Calls
$38.9M
Puts
$7.86M
Net Calls
+$31.1M
Net Calls Change
+$62.9M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$395M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$196M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$272M
4
FCM
4
Farallon Capital Management
California
$105M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$67.8M

Top Sellers

1
NHAS
1
Novo Holdings A/S
Denmark
$37.2M
2
EAM
2
Eventide Asset Management
Massachusetts
$7.38M
3
Fidelity International
3
Fidelity International
Bermuda
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$1.04M
5
Morgan Stanley
5
Morgan Stanley
New York
$6.49M
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
$21M +$2.45M +42,870 +13%
SAM
27
Sectoral Asset Management
Quebec, Canada
$17.1M -$452K -7,900 -3%
UBS AM
28
UBS AM
Illinois
$16.2M -$2.56M -44,797 -14%
DekaBank Deutsche Girozentrale
29
DekaBank Deutsche Girozentrale
Germany
$15.7M -$1.08M -20,100 -6%
Alkeon Capital Management
30
Alkeon Capital Management
New York
$15.6M +$15.6M +272,329 New
FCMI
31
Foresite Capital Management III
California
$14.4M -$1.6M -27,890 -10%
GIM
32
Granahan Investment Management
Massachusetts
$13.6M +$624K +10,895 +5%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$13.4M +$13.4M +234,271 New
FCMI
34
Foresite Capital Management II
California
$12.6M -$1.4M -24,488 -10%
Charles Schwab
35
Charles Schwab
California
$12.2M +$473K +8,257 +4%
UBS Group
36
UBS Group
Switzerland
$11.3M +$273K +4,775 +2%
QF
37
QVT Financial
New York
$10.9M – – –
Bank of New York Mellon
38
Bank of New York Mellon
New York
$10.8M +$1.05M +18,286 +11%
Federated Hermes
39
Federated Hermes
Pennsylvania
$10.8M +$10.5M +184,178 +3,664%
TCM
40
Tekla Capital Management
Massachusetts
$9.77M – – –
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$8.69M +$847K +14,792 +11%
Principal Financial Group
42
Principal Financial Group
Iowa
$8.65M -$739K -12,922 -8%
American Century Companies
43
American Century Companies
Missouri
$8.56M -$226K -3,941 -3%
EAM
44
Eventide Asset Management
Massachusetts
$7.38M -$22.9M -401,000 -76%
SLG
45
Stanley-Laman Group
Pennsylvania
$7.16M +$7.16M +125,020 New
CS
46
Candriam SCA
Luxembourg
$7.15M +$1.6M +28,000 +29%
Lord, Abbett & Co
47
Lord, Abbett & Co
New Jersey
$7.12M +$575K +10,051 +9%
TCIM
48
TIAA CREF Investment Management
New York
$6.91M +$1.03M +17,986 +17%
Hudson Bay Capital Management
49
Hudson Bay Capital Management
Connecticut
$6.87M -$1.72M -30,000 -20%
Morgan Stanley
50
Morgan Stanley
New York
$6.49M -$9.69M -169,208 -60%
1
2
3 4 5